Correlation Between Monte Rosa and Inhibrx

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Monte Rosa and Inhibrx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monte Rosa and Inhibrx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monte Rosa Therapeutics and Inhibrx, you can compare the effects of market volatilities on Monte Rosa and Inhibrx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monte Rosa with a short position of Inhibrx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monte Rosa and Inhibrx.

Diversification Opportunities for Monte Rosa and Inhibrx

-0.09
  Correlation Coefficient

Good diversification

The 3 months correlation between Monte and Inhibrx is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Monte Rosa Therapeutics and Inhibrx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibrx and Monte Rosa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monte Rosa Therapeutics are associated (or correlated) with Inhibrx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibrx has no effect on the direction of Monte Rosa i.e., Monte Rosa and Inhibrx go up and down completely randomly.

Pair Corralation between Monte Rosa and Inhibrx

Given the investment horizon of 90 days Monte Rosa Therapeutics is expected to generate 5.45 times more return on investment than Inhibrx. However, Monte Rosa is 5.45 times more volatile than Inhibrx. It trades about 0.1 of its potential returns per unit of risk. Inhibrx is currently generating about -0.05 per unit of risk. If you would invest  487.00  in Monte Rosa Therapeutics on September 23, 2024 and sell it today you would earn a total of  206.00  from holding Monte Rosa Therapeutics or generate 42.3% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Monte Rosa Therapeutics  vs.  Inhibrx

 Performance 
       Timeline  
Monte Rosa Therapeutics 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Monte Rosa Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Monte Rosa exhibited solid returns over the last few months and may actually be approaching a breakup point.
Inhibrx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Inhibrx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental drivers, Inhibrx is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Monte Rosa and Inhibrx Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Monte Rosa and Inhibrx

The main advantage of trading using opposite Monte Rosa and Inhibrx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monte Rosa position performs unexpectedly, Inhibrx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibrx will offset losses from the drop in Inhibrx's long position.
The idea behind Monte Rosa Therapeutics and Inhibrx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
CEOs Directory
Screen CEOs from public companies around the world
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets